Yet, it is worth considering that not every CRC carries alterations in all four driver pathways (WNT, EGFR, TGF‐beta/BMP and p53) and thus may still depend on stromal factors for further progression. This evidence concerns the gene TGFB1 and colorectal carcinoma.